UnitedHealth Reportedly Draws Bids Worth $1B For Banmedica In Latin America Exit

Published 09-06-2025, 07:53 pm
Updated 09-06-2025, 08:16 pm
© Reuters.  UnitedHealth Reportedly Draws Bids Worth $1B For Banmedica In Latin America Exit

Stocktwits - UnitedHealth Group (NYSE:UNH) is reportedly evaluating several non-binding offers for its Banmedica subsidiary in Latin America as the U.S. health insurance giant continues its retreat from the region.

UnitedHealth’s stock edged 0.8% higher in morning trade on Monday.

According to a report by Reuters, the company has received four preliminary bids for Banmedica, which operates in Chile and Colombia, valued at roughly $1 billion. A deadline for binding proposals could be set as early as July.

Interested parties reportedly include Washington, D.C.-based private equity firm Acon Investments, Brazilian asset manager Patria Investments, Texas-based nonprofit Christus Health, and Peru’s Auna, a healthcare and insurance provider.

Reuters added that Auna is reportedly in talks with a financial partner to support its offer.

UnitedHealth acquired Banmedica in 2018 under the leadership of then-CEO David Wichmann, who described the deal as laying a long-term growth foundation in South America.

However, UnitedHealth began reconsidering its Latin America strategy in 2022 amid mounting losses at its Brazilian unit, Amil, which it exited in late 2023.

Although Banmedica remains profitable, sources told Reuters it is no longer seen as a strategic fit for UnitedHealth, which posted an $8.3 billion loss last year tied to its South American operations – $7.1 billion from Brazil and $1.2 billion from Banmedica – largely due to currency translation losses.

The latest divestment efforts come as UnitedHealth faces pressure on multiple fronts, including an earnings shortfall and the abrupt resignation of CEO Andrew Witty. Meanwhile, a Wall Street Journal report stated that the company is under a criminal investigation for alleged Medicare fraud.

New CEO Steve Hemsley told shareholders last week that he is committed to restoring trust and stabilizing the business.

UnitedHealth’s stock has fallen nearly 40% this year.

Read also: Qualcomm (NASDAQ:QCOM) To Buy UK’s Alphawave Semi In $2.4B Deal To Bolster Data Center Strategy

This content is provided by Stocktwits

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.